Axis Healthcare

Axis Healthcare offers Spravato at its Sapulpa, Oklahoma location for adults with treatment-resistant depression. The FDA-approved esketamine nasal spray is administered in a supervised clinical environment and works through a different mechanism than traditional antidepressants, offering a faster-acting option.

Patients begin with a consultation to confirm eligibility, then self-administer the nasal spray under medical supervision. Each visit includes a two-hour observation period, and patients arrange transportation since they cannot drive for 24 hours after treatment.

The typical plan involves two sessions per week for the first month, tapering as symptoms improve. Axis Healthcare emphasizes compassionate, personalized care with ongoing monitoring and follow-up to support each patient's progress.